Lung Cancer:: Prevention, Management, and Emerging Therapies (Current Clinical Oncology)

0 avg rating
( 0 ratings by Goodreads )
 
9781607615231: Lung Cancer:: Prevention, Management, and Emerging Therapies (Current Clinical Oncology)
View all copies of this ISBN edition:
 
 

Defining the Lung Cancer Problem 1 Lung cancer is the leading cause of cancer death in the world. It kills almost as many Americans as cancers of the breast, prostate, colon, rectum, pancreas, and 2 kidney combined, and accounts for 28.6% of all US cancer deaths. With an increase in the 5-year relative survival rate from 13% to only 16% in the more than 2 30 years from 1974 to the present, it will take us another 840 years to eradicate lung cancer deaths if we do not improve the current rate of progress. As discussed in this text, lung cancer prevention has received substantial att- tion. The decrease in smoking in recent decades has helped, but smoking is not the only problem. Lung cancer in people who have never smoked is currently the 5th 3 leading cause of cancer death in the United States. Several factors contribute to the lethality of lung cancer, including the rapidity of tumor growth, advanced stage at diagnosis (due to nonspecificity of early sy- toms and the uncertain efficacy of screening), early development of metastases, and resistance to therapy. Several chapters in this book discuss new molecular targets that may be potentially exploitable in the future, as well as discussing our track record to date in exploiting them.

"synopsis" may belong to another edition of this title.

From the Back Cover:

This comprehensive resource provides authoritative knowledge of the most up-to-date prevention and treatment strategies for thoracic malignancies. Established and investigational therapies are placed in the context of tumor biology for a full understanding of the pharmacogenetics, etiology, and changing epidemiology of lung cancer. Expert clinicians detail the function of predictive and prognostic factors in the utilization of chemo-radiotherapy, adjuvant and neoadjuvant treatment, and targeted agents. The promises and potential pitfalls of investigational strategies are evaluated with exceptional insight and clarity, with unique attention paid to the mechanisms of drug resistance and targets for lung cancer treatment and prevention. Lung Cancer: Prevention, Management, and Emerging Therapies engages the entire spectrum of therapeutic modalities with focus on systemic approaches. Disease coverage includes newly diagnosed and recurrent non-small cell lung cancer, small cell carcinoma, and mesothelioma. Critical examination of the impact, methodology, and design of clinical trials is presented along with new paradigms for personalized approaches and individual risk assessment.

Review:

From the reviews:

“This comprehensive review of prevention and treatment strategies for malignancies of the thorax thoroughly investigates tumor biology and discusses established and emerging therapies. ... The book is written for a wide audience that includes pathologists, pulmonologists, medical oncologists, radiation oncologists, and surgical oncologists. ... I would highly recommend this book to anyone interested in current and future therapies for lung cancer. This is one of the most comprehensive and up-to-date accounts of the field.” (Nagendra S. Koneru, Doody’s Review Service, July, 2010)

"About this title" may belong to another edition of this title.

Other Popular Editions of the Same Title

9781617796845: Lung Cancer:: Prevention, Management, and Emerging Therapies (Current Clinical Oncology)

Featured Edition

ISBN 10:  1617796840 ISBN 13:  9781617796845
Publisher: Humana Press, 2012
Softcover

Top Search Results from the AbeBooks Marketplace

1.

David J. Stewart (Editor)
Published by Humana Press (2010)
ISBN 10: 1607615231 ISBN 13: 9781607615231
New Hardcover Quantity Available: 1
Seller:
Ergodebooks
(RICHMOND, TX, U.S.A.)
Rating
[?]

Book Description Humana Press, 2010. Hardcover. Condition: New. 2010. Seller Inventory # DADAX1607615231

More information about this seller | Contact this seller

Buy New
US$ 87.78
Convert currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, rates & speeds

2.

Published by Humana Press (2010)
ISBN 10: 1607615231 ISBN 13: 9781607615231
New Hardcover Quantity Available: 1
Seller:
Irish Booksellers
(Portland, ME, U.S.A.)
Rating
[?]

Book Description Humana Press, 2010. Condition: New. book. Seller Inventory # M1607615231

More information about this seller | Contact this seller

Buy New
US$ 109.85
Convert currency

Add to Basket

Shipping: US$ 3.27
Within U.S.A.
Destination, rates & speeds

3.

Published by Humana Press Inc., United States (2011)
ISBN 10: 1607615231 ISBN 13: 9781607615231
New Hardcover Quantity Available: 1
Seller:
Book Depository International
(London, United Kingdom)
Rating
[?]

Book Description Humana Press Inc., United States, 2011. Hardback. Condition: New. Language: English. Brand new Book. Defining the Lung Cancer Problem 1 Lung cancer is the leading cause of cancer death in the world. It kills almost as many Americans as cancers of the breast, prostate, colon, rectum, pancreas, and 2 kidney combined, and accounts for 28.6% of all US cancer deaths. With an increase in the 5-year relative survival rate from 13% to only 16% in the more than 2 30 years from 1974 to the present, it will take us another 840 years to eradicate lung cancer deaths if we do not improve the current rate of progress. As discussed in this text, lung cancer prevention has received substantial att- tion. The decrease in smoking in recent decades has helped, but smoking is not the only problem. Lung cancer in people who have never smoked is currently the 5th 3 leading cause of cancer death in the United States. Several factors contribute to the lethality of lung cancer, including the rapidity of tumor growth, advanced stage at diagnosis (due to nonspecificity of early sy- toms and the uncertain efficacy of screening), early development of metastases, and resistance to therapy. Several chapters in this book discuss new molecular targets that may be potentially exploitable in the future, as well as discussing our track record to date in exploiting them. Seller Inventory # LIB9781607615231

More information about this seller | Contact this seller

Buy New
US$ 232.45
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

4.

Published by Humana Press Inc., United States (2011)
ISBN 10: 1607615231 ISBN 13: 9781607615231
New Hardcover Quantity Available: 1
Seller:
The Book Depository
(London, United Kingdom)
Rating
[?]

Book Description Humana Press Inc., United States, 2011. Hardback. Condition: New. Language: English. Brand new Book. Defining the Lung Cancer Problem 1 Lung cancer is the leading cause of cancer death in the world. It kills almost as many Americans as cancers of the breast, prostate, colon, rectum, pancreas, and 2 kidney combined, and accounts for 28.6% of all US cancer deaths. With an increase in the 5-year relative survival rate from 13% to only 16% in the more than 2 30 years from 1974 to the present, it will take us another 840 years to eradicate lung cancer deaths if we do not improve the current rate of progress. As discussed in this text, lung cancer prevention has received substantial att- tion. The decrease in smoking in recent decades has helped, but smoking is not the only problem. Lung cancer in people who have never smoked is currently the 5th 3 leading cause of cancer death in the United States. Several factors contribute to the lethality of lung cancer, including the rapidity of tumor growth, advanced stage at diagnosis (due to nonspecificity of early sy- toms and the uncertain efficacy of screening), early development of metastases, and resistance to therapy. Several chapters in this book discuss new molecular targets that may be potentially exploitable in the future, as well as discussing our track record to date in exploiting them. Seller Inventory # LIB9781607615231

More information about this seller | Contact this seller

Buy New
US$ 240.77
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

5.

David J. Stewart
Published by Humana Press Inc. (2010)
ISBN 10: 1607615231 ISBN 13: 9781607615231
New Quantity Available: > 20
Print on Demand
Seller:
Pbshop
(Wood Dale, IL, U.S.A.)
Rating
[?]

Book Description Humana Press Inc., 2010. HRD. Condition: New. New Book. Shipped from US within 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # IQ-9781607615231

More information about this seller | Contact this seller

Buy New
US$ 271.32
Convert currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, rates & speeds

6.

David J. Stewart (editor)
Published by Humana Press 2010-02-01, New York (2010)
ISBN 10: 1607615231 ISBN 13: 9781607615231
New Hardcover Quantity Available: > 20
Seller:
Blackwell's
(Oxford, OX, United Kingdom)
Rating
[?]

Book Description Humana Press 2010-02-01, New York, 2010. hardback. Condition: New. Seller Inventory # 9781607615231

More information about this seller | Contact this seller

Buy New
US$ 284.61
Convert currency

Add to Basket

Shipping: US$ 9.86
From United Kingdom to U.S.A.
Destination, rates & speeds

7.

Stewart, David J. (Editor)
Published by Humana Pr Inc (2009)
ISBN 10: 1607615231 ISBN 13: 9781607615231
New Hardcover Quantity Available: 1
Seller:
Revaluation Books
(Exeter, United Kingdom)
Rating
[?]

Book Description Humana Pr Inc, 2009. Hardcover. Condition: Brand New. 1st edition. 538 pages. 9.25x6.25x1.50 inches. In Stock. Seller Inventory # __1607615231

More information about this seller | Contact this seller

Buy New
US$ 297.74
Convert currency

Add to Basket

Shipping: US$ 9.86
From United Kingdom to U.S.A.
Destination, rates & speeds

8.

Published by Humana Press (2010)
ISBN 10: 1607615231 ISBN 13: 9781607615231
New Hardcover Quantity Available: 1
Seller:
Rating
[?]

Book Description Humana Press, 2010. Condition: New. Seller Inventory # L9781607615231

More information about this seller | Contact this seller

Buy New
US$ 321.64
Convert currency

Add to Basket

Shipping: US$ 3.21
From Germany to U.S.A.
Destination, rates & speeds

9.

DAVID J. STEWART
Published by Humana Press (2010)
ISBN 10: 1607615231 ISBN 13: 9781607615231
New Hardcover Quantity Available: 1
Seller:
Herb Tandree Philosophy Books
(Stroud, GLOS, United Kingdom)
Rating
[?]

Book Description Humana Press, 2010. Hardback. Condition: NEW. 9781607615231 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. For all enquiries, please contact Herb Tandree Philosophy Books directly - customer service is our primary goal. Seller Inventory # HTANDREE0308385

More information about this seller | Contact this seller

Buy New
US$ 327.53
Convert currency

Add to Basket

Shipping: US$ 10.49
From United Kingdom to U.S.A.
Destination, rates & speeds

10.

David J. Stewart
Published by Springer-Verlag Gmbh Mrz 2010 (2010)
ISBN 10: 1607615231 ISBN 13: 9781607615231
New Quantity Available: 1
Seller:
BuchWeltWeit Inh. Ludwig Meier e.K.
(Bergisch Gladbach, Germany)
Rating
[?]

Book Description Springer-Verlag Gmbh Mrz 2010, 2010. Buch. Condition: Neu. Neuware - Defining the Lung Cancer Problem 1 Lung cancer is the leading cause of cancer death in the world. It kills almost as many Americans as cancers of the breast, prostate, colon, rectum, pancreas, and 2 kidney combined, and accounts for 28.6% of all US cancer deaths. With an increase in the 5-year relative survival rate from 13% to only 16% in the more than 2 30 years from 1974 to the present, it will take us another 840 years to eradicate lung cancer deaths if we do not improve the current rate of progress. As discussed in this text, lung cancer prevention has received substantial att- tion. The decrease in smoking in recent decades has helped, but smoking is not the only problem. Lung cancer in people who have never smoked is currently the 5th 3 leading cause of cancer death in the United States. Several factors contribute to the lethality of lung cancer, including the rapidity of tumor growth, advanced stage at diagnosis (due to nonspecificity of early sy- toms and the uncertain efficacy of screening), early development of metastases, and resistance to therapy. Several chapters in this book discuss new molecular targets that may be potentially exploitable in the future, as well as discussing our track record to date in exploiting them. 538 pp. Englisch. Seller Inventory # 9781607615231

More information about this seller | Contact this seller

Buy New
US$ 321.64
Convert currency

Add to Basket

Shipping: US$ 20.00
From Germany to U.S.A.
Destination, rates & speeds

There are more copies of this book

View all search results for this book